Dl. Hudson et al., ALTERED EXPRESSION OF CD44 ISOFORMS IN SQUAMOUS-CELL CARCINOMAS AND CELL-LINES DERIVED FROM THEM, International journal of cancer, 66(4), 1996, pp. 457-463
CD44 is a transmembrane glycoprotein that binds hyaluronan, extracellu
lar matrix proteins and growth factors. Multiple isoforms of CD44 ave
generated by alternative splicing of 10 separate exons (VI-V10). Expre
ssion of the variable exons has been correlated with tumour progressio
n and metastasis in a range of cell types. However, multiple CD44 isof
orms are expressed by normal stratified squamous epithelia, such as th
e epidermis and the lining of the oral cavity. The purpose of our stud
y was to examine CD44 expression in squamous-cell carcinomas (SCC). By
immunofluorescence we found reduced expression of one or more of the
variant exons in a series of 13 oral SCC, with loss being most common
in poorly differentiated tumours. Of the exons we examined, V3 was los
t most frequently, but otherwise there was no consistent pattern as to
which exons (V4/5, 6, 8) were missing. We also studied CD44 expressio
n in a range of SCC lines, using Western blotting and semi-quantitativ
e RT-PCR. All lines showed reduced expression of the terminal differen
tiation marker involucrin. Two lines showed selective loss of the larg
est forms of CD44 and one failed to express any of the variant exons.
These cell lines, therefore, provide a useful experimental model with
which to study the biological significance of exon loss in SCC. (C) 19
96 Wiley-Liss, Inc.